Besides TP53 and APC mutations, which were both more common in non-CDX2-suppressed colorectal cancers, CDX2-suppressed cancers had a higher prevalence of mutations in other DDR-related and WNT/APC/β-catenin pathway genes. The gene discussed is CDX2; the disease is colorectal cancer.